Innovent’s CDMO gets green light to make biologics at large Chinese plant
BioSpace
The license, which Innovent's Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant's capacity to 172,000 liters.
pharminent
April 9, 2026 (Last updated: April 9, 2026)
BioSpace
The license, which Innovent’s Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant’s capacity to 172,000 liters.
